- Associated Press - Friday, September 18, 2015

FREDERICK, Md. (AP) - The city of Frederick has finalized a loan package that will approve expansion of MedImmune’s Frederick biotech manufacturing plant and improve roads around the business.

The Frederick News-Post (https://bit.ly/1KlsVTM ) reports that the Board of Aldermen voted Thursday to approve a series of agreements between the company, the city and the State Highway Administration to reimburse the AstraZeneca-owned firm nearly $7 million to fund nearby road improvements.

The city of Frederick will reimburse the firm over 15 years for design and construction of an extra lane and additional off-ramps from state Route 180 to U.S. Highway 340.

City Economic Development Director Richard Griffin says the projects will improve traffic flow in the area.

MedImmune announced plans for a $200 million expansion late last year.


Information from: The Frederick (Md.) News-Post, https://www.fredericknewspost.com

Sign up for Daily Newsletters

Copyright © 2019 The Washington Times, LLC.

The Washington Times Comment Policy

The Washington Times welcomes your comments on Spot.im, our third-party provider. Please read our Comment Policy before commenting.


Click to Read More and View Comments

Click to Hide